http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004069276-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083 |
| filingDate | 2004-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2004069276-A1 |
| titleOfInvention | Prevention, suppression or treatment of adhesion formation |
| abstract | The problem of the present invention is, for example, before or after various surgical steps including orthopedic or plastic surgery such as heart, chest, gynecological, eye disease, abdomen, etc., or due to trauma or inflammation etc. To provide a drug capable of effectively preventing, suppressing or treating adhesion formation when visceral adhesion is a concern. By medicament comprising at least one effective amount of protease inhibitor by intravenous, oral or transdermal application. The protease inhibitor is preferably a serine protease inhibitor, and the serine protease inhibitor is a chymotrypsin-like serine protease inhibitor. Specifically, it is a chymase inhibitor and is a peptide derivative of an aryl diester of α-aminoalkylphosphonic acid which is Suc-Val-Pro-Phe P (OPh) 2 , preferably the enantiomer Suc-Val-Pro -L-Phe P (OPh) 2. |
| priorityDate | 2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 355.